# A Post-market Study to Evaluate the Effects of Sodium Hyaluronate Based Eye Drops in Patients Affected by Dry Eye Disease

> **NCT05773963** · NA · TERMINATED · sponsor: **Montefarmaco OTC SpA** · enrollment: 80 (actual)

## Conditions studied

- Opthalomology/Dry Eye

## Interventions

- **DEVICE:** Irilens; Iridina; Afomill Lubricating Eye Drops

## Key facts

- **NCT ID:** NCT05773963
- **Lead sponsor:** Montefarmaco OTC SpA
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2022-02-24
- **Primary completion:** 2024-06-25
- **Final completion:** 2024-06-25
- **Target enrollment:** 80 (ACTUAL)
- **Why stopped:** Low enrollment rate
- **Last updated:** 2025-05-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05773963

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05773963, "A Post-market Study to Evaluate the Effects of Sodium Hyaluronate Based Eye Drops in Patients Affected by Dry Eye Disease". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT05773963. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*